Colgate-Palmolive (CL) Stake Maintained by Adalta Capital Management LLC
Adalta Capital Management LLC continued to hold its stake in shares of Colgate-Palmolive (NYSE:CL) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,660 shares of the company’s stock at the end of the 2nd quarter. Adalta Capital Management LLC’s holdings in Colgate-Palmolive were worth $642,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in CL. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter worth approximately $102,000. Proficio Capital Partners LLC lifted its holdings in Colgate-Palmolive by 16.9% in the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after purchasing an additional 207 shares during the last quarter. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive in the 2nd quarter worth approximately $109,000. Krilogy Financial LLC lifted its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the last quarter. Finally, Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive in the 1st quarter worth approximately $121,000. Institutional investors and hedge funds own 72.96% of the company’s stock.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now directly owns 60,528 shares in the company, valued at $4,422,780.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Justin Skala sold 126,393 shares of the company’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total value of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares in the company, valued at $19,144,482.17. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,673 shares of company stock worth $12,629,293. 1.02% of the stock is currently owned by company insiders.
Several research firms recently weighed in on CL. SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and boosted their target price for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Citigroup cut their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Stifel Nicolaus set a $73.00 price target on Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday, October 29th. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a report on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $76.04.
Shares of Colgate-Palmolive (NYSE CL) opened at $73.32 on Friday. The stock has a market capitalization of $64,382.66, a P/E ratio of 25.55, a PEG ratio of 3.36 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. Colgate-Palmolive’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.73 earnings per share. analysts predict that Colgate-Palmolive will post 2.88 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 61.78%.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.